KDventures AB (OTCPK:KDEVF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
KDventures AB's Enterprise Value for the quarter that ended in Mar. 2026 was $158.51 Mil.
KDventures AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.12 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KDventures AB EV-to-EBIT Related Terms
KDventures AB EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for KDventures AB's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, KDventures AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KDventures AB EV-to-EBIT vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, KDventures AB's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where KDventures AB's EV-to-EBIT falls into.
KDventures AB's current Enterprise Value is $8.64 Mil.
KDventures AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.12 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KDventures AB (KDEVF) has a EV-to-EBIT of -4.07 as of Jul. 04, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on KDventures AB and its competitors. According to the industry distribution chart, KDventures AB ranks #999999 out of 367 companies in the Biotechnology industry.
Is KDventures AB's EV-to-EBIT too high?
KDventures AB's current EV-to-EBIT is -4.07. Based on the distribution chart, KDventures AB ranks #999999 out of 367 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, KDventures AB has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does KDventures AB's EV-to-EBIT compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, KDventures AB ranks #999999 out of 367 companies for EV-to-EBIT. This places KDventures AB in the lower half of its industry. The industry median EV-to-EBIT is 15.43. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Biotechnology company?
The median EV-to-EBIT among Biotechnology companies is 15.43, based on 367 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on KDventures AB and its competitors. For the Biotechnology industry, the median EV-to-EBIT is 15.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KDventures AB's current EV-to-EBIT is -4.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KDventures AB stock overvalued right now?
KDventures AB (KDEVF) has a current EV-to-EBIT of -4.07. The stock's GF Value™ is $0.65, compared to a current price of $0.26 — trading 60.4% below its estimated fair value. The current EV-to-EBIT is -4.07. KDventures AB's overall GF Score™ is 27/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For KDventures AB (KDEVF), the current EV-to-EBIT is -4.07 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KDventures AB (KDEVF) Overvalued in 2026?
Based on GuruFocus' analysis, KDventures AB stock appears to be undervalued.
The current stock price of $0.26 is trading 60.4% below its estimated GF Value™ of $0.65.
Key valuation signals for KDEVF:
EV-to-EBIT: -4.07
GF Value™: $0.65 vs. price of $0.26 (60.4% below fair value)
No single metric tells the full story. See the KDEVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KDventures AB is a Nordic investment company specialized in life sciences. The company identifies and invests in pharmaceutical projects and medical technology products originating from research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, the company creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with value growth potential.
27GF Score
Get the complete analysis for KDEVF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KDEVF has been successfully added to your 
